Terns Pharmaceuticals (TERN) Preferred Stock Liabilities (2020)
Terns Pharmaceuticals' Preferred Stock Liabilities history spans 1 years, with the latest figure at $69.0 million for Q4 2020.
- For Q4 2020, Preferred Stock Liabilities changed N/A year-over-year to $69.0 million; the TTM value through Dec 2020 reached $69.0 million, changed N/A, while the annual FY2020 figure was $69.0 million, N/A changed from the prior year.
- Preferred Stock Liabilities reached $69.0 million in Q4 2020 per TERN's latest filing, up from $21.9 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $73.0 million in Q1 2020 to a low of $21.9 million in Q3 2020.